• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hamilton Lane Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    10/6/25 4:23:40 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    hlne-20251001
    0001433642false00014336422025-10-012025-10-01


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): October 1, 2025
    Hamilton Lane Incorporated
    (Exact Name of Registrant as specified in its charter)
    Delaware001-3802126-2482738
    (State or other jurisdiction of incorporation)
    (Commission File No.)(IRS Employer Identification No.)
    110 Washington Street,Suite 1300
    Conshohocken, PA19428
    (Address of principal executive offices)
    (Zip Code)
     (610) 934-2222 
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, $0.001 par value per shareHLNEThe Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



    Item 1.01. Entry into a Material Definitive Agreement.
    On October 1, 2025, Hamilton Lane Advisors, L.L.C. (“HLA”), the operating subsidiary of Hamilton Lane Incorporated, entered into a Second Amendment to the Multi-Draw Term Loan and Security Agreement (the “Second Amendment”) with JPMorgan Chase Bank, N.A. (“JPM”), amending the Multi-Draw Term Loan and Security Agreement, dated as of October 20, 2022, between JPM and HLA (as previously amended, the “2022 Term Loan Agreement”).

    The 2022 Term Loan Agreement provides for term loans in the aggregate principal amount of $75 million, subject to an aggregate cap of loans that may be outstanding under all of HLA’s loan agreements with JPM of $325 million (the “Cap”). Borrowings under the 2022 Term Loan Agreement accrue interest at a rate equal to the greater of (a) the Prime Rate (as defined therein) minus 1.50% and (b) 3.00%. The Second Amendment to the 2022 Term Loan Agreement, among other things, (a) changes the aggregate principal amount of terms loans from $75 million to $50 million, subject to the Cap, (b) changes certain dates related to interest payments and repayments of the term loans thereunder, and (c) changes the interest rate for borrowings thereunder to equal the greater of (a) the Prime Rate minus 1.35% and (b) 3.00%.

    The foregoing description does not purport to be complete and is qualified in its entirety by reference to the new agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information included in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits
    Exhibit 
    No.
    Description
    10.1º
    Multi-Draw Term Loan and Security Agreement, dated October 20, 2022, between JPMorgan Chase Bank, N.A. and Hamilton Lane Advisors, L.L.C. (conformed through Second Amendment).
    104Cover page Interactive Data File (embedded within the Inline XBRL document)
    º Confidential information in this exhibit has been omitted.





    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    HAMILTON LANE INCORPORATED
    Date: October 6, 2025
    By:/s/ Lydia A. Gavalis
    Name:Lydia A. Gavalis
    Title:General Counsel and Secretary


    Get the next $HLNE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    More analyst ratings

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Novata Acquires Atlas Metrics to Power the Future of Sustainability Data Management

    Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th

    10/7/25 7:10:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Launches Global Venture Capital and Growth Evergreen Fund, Adding to its $13B+ AUM1 Evergreen Platform

    The Fund offers access to innovative private venture and growth investments not available in the public markets  LONDON, Oct. 1, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Global Venture Capital and Growth Fund ("HLGVG" or "the Fund"), an evergreen investment vehicle focused on growth and venture opportunities in the private markets. The Fund is available to certain individual investors and their advisors, as well as institutional investors, in parts of Europe, Asia, Latin America and the Middle East, as well as in Australia, New Zealand and Canada.  HLGVG offers investors access to the firm's glo

    10/1/25 2:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    PAX Health Acquires Neuropsychology and Counseling Associates, Expanding Comprehensive Mental Health Services Across New Jersey

    RED BANK, N.J., Sept. 23, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Neuropsychology and Counseling Associates, a comprehensive outpatient mental health practice serving children, adolescents, adults, and families throughout New Jersey. This strategic acquisition enhances PAX Health's portfolio of specialized mental health services and expands its geographic footprint in New Jersey, strengthening the company's ability to deliver neuropsycho

    9/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Sexton O Griffith was granted 1,331 shares, increasing direct ownership by 38% to 4,852 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:01:35 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Varon Leslie F was granted 666 shares, increasing direct ownership by 7% to 9,658 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:00:52 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Hamilton Lane with a new price target

    BMO Capital Markets initiated coverage of Hamilton Lane with a rating of Outperform and set a new price target of $150.00

    10/3/25 8:40:27 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Sell to Neutral and set a new price target of $162.00

    9/18/25 8:33:14 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane downgraded by Oppenheimer

    Oppenheimer downgraded Hamilton Lane from Outperform to Perform

    5/15/25 8:08:14 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    Hamilton Lane Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    10/6/25 4:23:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/5/25 4:29:27 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/4/25 4:16:11 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

    Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

    2/10/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    Novata Acquires Atlas Metrics to Power the Future of Sustainability Data Management

    Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th

    10/7/25 7:10:00 AM ET
    $HLNE
    Investment Managers
    Finance

    PAX Health Acquires Neuropsychology and Counseling Associates, Expanding Comprehensive Mental Health Services Across New Jersey

    RED BANK, N.J., Sept. 23, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Neuropsychology and Counseling Associates, a comprehensive outpatient mental health practice serving children, adolescents, adults, and families throughout New Jersey. This strategic acquisition enhances PAX Health's portfolio of specialized mental health services and expands its geographic footprint in New Jersey, strengthening the company's ability to deliver neuropsycho

    9/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Pa., Aug. 5, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the first fiscal quarter ended June 30, 2025. The Company issued a full detailed presentation of its first quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/ Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on September 19, 2025 that will be paid on October 6, 2025. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    8/5/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance